Type
1.
Harrison R, Williams D. Outlining progress since the first International Snakebite Awareness Day and some key challenges for next year. Transactions of the Royal Society of Tropical Medicine and Hygiene [Internet]. 2019; Available from: https://academic.oup.com/trstmh/article/113/10/577/5569788
Type
1.
Musah Y, Ameade E, Attuquayefio D, Holbech L. Epidemiology, ecology and human perceptions of snakebites in a savanna community of northern Ghana. PLoS neglected tropical diseases [Internet]. 2019;13(8):e0007221. Available from: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0007221&type=printable
Type
1.
Williams H, Layfield H, Vallance T, Patel K, Bicknell A, Trim S, et al. The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites. Toxins [Internet]. 2019;11(6). Available from: https://www.mdpi.com/2072-6651/11/6/363
Type
1.
Tekin, Sula, Cakır, Aktar, Deveci, Yolbas, et al. Comparison of snakebite cases in children and adults. European review for medical and pharmacological sciences [Internet]. 2015;19(14):2711-6. Available from: https://www.europeanreview.org/wp/wp-content/uploads/2711-2716.pdf
Type
1.
Wijesinghe C, Williams S, Kasturiratne A, Dolawaththa N, Wimalaratne P, Wijewickrema B, et al. A randomized controlled trial of a brief intervention for delayed psychological effects in snakebite victims. PLoS neglected tropical diseases [Internet]. 2015;9(8):e0003989. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532481/pdf/pntd.0003989.pdf
Type
1.
Silva A, Ryan N, Silva J. Adverse reactions to snake antivenom, and their prevention and treatment. British journal of clinical pharmacology [Internet]. 2016;81(3):446-52. Available from: https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.12739
Type
1.
Habib A, Lamorde M, Dalhat M, Habib Z, Kuznik A. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria. PLoS neglected tropical diseases [Internet]. 2015;9(1):e3381. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0003381&type=printable
Type
1.
Gutiérrez JM, Burnouf T, Harrison R, Calvete J, Kuch U, Warrell D, et al. A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming. Bulletin of the World Health Organization [Internet]. 2014;92(7):526-32. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121869/pdf/BLT.13.132431.pdf
Type
1.
Gutiérrez JM. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead. Transactions of the Royal Society of Tropical Medicine and Hygiene [Internet]. 2014;108(9):530-7. Available from: https://redtox.org/sites/default/files/toxiblog/descargables/2014-reducing-the-impact-of-snakebite-envenoming-in-latin-america-clodomiro_1.pdf
Type
1.
Longbottom J, Shearer F, Devine M, Alcoba G, Chappuis F, Weiss D, et al. Vulnerability to snakebite envenoming: a global mapping of hotspots. The lancet [Internet]. 2018;:12. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6115328/pdf/main.pdf
Pagination
- Page 1
- Next page